News

The Persistent Problem of PFAS Per- and polyfluoroalkyl substances (PFAS), often dubbed "forever chemicals," have become one of the most pressing envi[...]

Phase II award from NIH’s National Institute of Dental & Craniofacial Research will drive development of MatriNova™, an amino acid-based nanofiber[...]

Baltimore, MD — Matregenix is proud to announce that we have won 1st Place and a $60,000 cash prize at the prestigious Health Security Innovation Chal[...]

Mission Viejo, California – January 30, 2025 – Matregenix Inc., a leader in nanofiber technology, is proud to announce that it has been awarded a Phas[...]

MISSION VIEJO, California., Sept. 11, 2024 - Matregenix announces it has been selected by AFWERX for three Phase II contracts: a Follow-on Phase II SB[...]

Mission Viejo, California - Matregenix Inc., a reputable name in nanofiber technology, proudly announces its selection by AFWERX for a Phase I SBIR co[...]

Mission Viejo, California – Matregenix Inc., a pioneering technology company based in California, is thrilled to announce the expansion of its operati[...]

Irvine, California – In a significant nod to its commitment to advancing healthcare technology, Matregenix, a dedicated player in the biomedical field[...]

Irvine, CA – Matregenix, a leading innovator in nanofiber technology, is thrilled to announce its recognition as the "Best Emerging Technology Company[...]

Irvine, CA – The University of California, Irvine (UCI) announce that the Master of Engineering Capstone Project, sponsored by Matregenix, Inc., has b[...]